Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 5, 1999, Pages 1284-1290

  Ivandic, Boris ^a,b   Castellani, Lawrence W ^a,b   Wang, Xu Ping ^a,b   Qiao, Jian Hua ^a,b   Mehrabian, Margarete ^a,b   Navab, Mohamad ^b   Fogelman, Alan M ^b   Grass, David S ^c   Swanson, Mark E ^c   De Beer, Maria C ^d   De Beer, Frederick ^d   Lusis, Aldons J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Chrysalis DNX Transgenic Sciences   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Inflammation; Lipoproteins; Paraoxonase

Indexed keywords

LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032941386     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.5.1284     Document Type: Article

References (35)

1. Kudo I, Murakami M, Hara S, Inoue K. Mammalian non-pancreatic phospholipases A2. Biochim Biophys Acta. 1993;1170:217-231.
2. Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994;269:13057-13060.
3. Tischfield JA. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J Biol Chem. 1997;272:17247-17250.
4. Sparrow CP, Parthasarathy S, Steinberg D. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J Lipid Res. 1988;29:745-753.
5. Sakai M, Miyazaki A, Hakamata H, Sasaki T, Yui S, Yamazaki M, Shichiri M, Horiuchi S. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem. 1994;269:31430-31435.
6. Mangin EL Jr, Kugiyama K, Nguy JH, Kerns SA, Henry PD. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res. 1993;72:161-166.
7. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured Human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
8. Grass DS, Felkner RH, Chiang M-Y, Wallace RE, Nevalainen TJ, Bennett CF, Swanson ME. Expression of human group II PLA2 in transgenic results in epidermal hyperplasia in the absence of inflammatory infiltrate. J Clin Invest. 1996;97:2233-2241.
9. Hurt-Camejo E, Andersen S, Standal R, Rosengren B, Sartipy P, Stadberh E, Johansen B. Localization of non-pancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Arterioscler Thromb Vasc Biol. 1997;17:300-309.
10. Menschikowski M, Kasper M, Lattke P, Schiering A, Schiefer S, Stockinger H, Jaross W. Secretory group II phospholipase A2 in human atherosclerotic lesions. Atherosclerosis. 1995;118:173-181.
11. Kennedy BP, Payette P, Mudgett J, Vadas P, Pruzanski W, Kwan M, Tang C, Rancourt DE, Cromlish WA. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem. 1995;270:22378-22385.
12. Qiao J-H, Xie P-Z, Fishbein MC, Kreuzer J, Drake TA, Demer LL, Lusis AJ. Pathology of the atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler Thromb. 1994;14:1480-1497.
13. Warden CH, Qiao JH, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 1993;261:469-472.
14. deBeer FC, deBeer MC, van der Westerhuyzen DR, Castellani LW, Lusis AJ, Swanson ME, Grass DS. Secretory non-pancreatic phospholipase A2:Influence on lipoprotein metabolism. J Lipid Res. 1997;38: 2232-2239.
15. Lorenzen A, Kennedy SW. A fluorescence based protein assay for use with a microplate reader. Anal Biochem. 1993;214:346-348.
16. Lowry OH, Rosebrough MJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
17. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos. 1991;19:100-106.
18. 2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. Arterioscler Thromb Vasc Biol. 1999;19:1291-1298.
19. Mackness MI, Arrol S. Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 1991;286: 152-154.
20. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 1995;96:2882-2891.
21. Parthasarathy, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990;1044:275-283.
22. Shih DM, Gu L, Hama S, Xia Y, Navab M, Fogelman AM, Lusis AJ. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest. 1996;97: 1630-1639.
23. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987;68: 231-240.
24. Weng W, Breslow JL. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein AII in atherosclerosis susceptibility. Proc Natl Acad Sci U S A. 1996;93:14788-14794.
25. Castellani LW, Navab M, van Lenten BJ, Hama S, Hedrick C, Fogelman AM, Lusis AJ. Apolipoprotein All overexpression converts the anti-inflammatory HDL to pro-inflammatory particles. J Clin Invest. 1997; 100:464-474.
26. Fielding CJ, Fielding PE. The molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-228.
27. Bielicke JK, Forte TM, McCall MR. Minimally oxidized LDL is a potent inhibitor of lecithin:cholesterol acyltransferase activity. J Lipid Res. 1996;37:1012-1021.
28. Pruzanski W, de Beer FC, de Beer MC, Stefanski E, Vadas P. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem J. 1995;309:461-464.
29. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ. Genetic control of inflammatory gene induction and NF-kB-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest. 1993;91: 2572-2579.
30. Liao F, Andalibi A, Qiao J-H, Allayee H. Fogelman AM, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest. 1994;94:877-884.
31. Van Lenten BJ, Hama SY, deBeer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell co-cultures. J Clin Invest. 1995;96:2758-2767.
32. Menschikowski M, Lattke P, Bergmann S, Jaross W. Exposure of macrophages to PLA2-modified lipoproteins leads to cellular lipid accumulations. Anal Cell Pathol. 1995;9:113-121.
33. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel S, Cathey MA. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481-494.
34. Rosenthal MD, Gordon MN, Buescher ES, Slusser JH, Harris LK, Franson RC. Human neutrophils store type II 14-kDa phospholipase A2 in granules and secrete active enzyme in response to soluble stimuli. Biochem Biophys Res Commun. 1995;208:650-656.
35. Arbibe L, Vial D, Rosinski-Chupin I, Havet N, Huerre M, Vargaftig BB, Touqui L. Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis. J Immunol. 1997;159:391-400.